Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11502894 | 0.90 | LTA4H (0.47) | — | |
| SCHEMBL10957293 | 0.89 | SLC6A4 (0.34) | SLC6A4 | |
| SCHEMBL11503114 | 0.81 | SLC6A2 (0.40) | KDM4ESLC6A4 | |
| SCHEMBL16784001 | 0.79 | OPRM1 (0.45) | SLC6A4 | |
| SCHEMBL8494832 | 0.79 | HRH3 (0.30) | SLC6A4 | |
| SCHEMBL8824942 | 0.79 | — | — | |
| SCHEMBL14157582 | 0.79 | CYP19A1 (0.38) | KDM4E | |
| SCHEMBL27286249 | 0.78 | RXRA (0.34) | — | |
| SCHEMBL10942041 | 0.77 | SLC6A4 (0.38) | SLC6A4 | |
| SCHEMBL11115039 | 0.77 | ACHE (0.39) | KDM4ESLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112961403-B | Recovery method of fiber-reinforced epoxy resin composite material | 上海第二工业大学 | 2023-02-03 | — | — | CN | disclosed |
| CN-112961403-A | Recovery method of fiber-reinforced epoxy resin composite material | 上海第二工业大学 | 2021-06-15 | — | — | CN | disclosed |
| CN-102031123-B | Composition for liquid crystal film, liquid crystal film and method of manufacturing the same | LG CHEMICAL INC | 2013-07-24 | — | — | CN | disclosed |
| WO-2011159120-A2 | MOLDING APPARATUS AND METHOD OF MANUFACTURING POLYMER MOLDED ARTICLE | LG INNOTEK CO., LTD. (KR) | 2011-12-22 | — | — | WO | disclosed |
| CN-1247478-C | Non-crystallization forming oligomers for radiation curable fiber lens coatings | DSM IP ASSETS BV (NL) | 2006-03-29 | — | — | CN | disclosed |
| CN-1484621-A | Non-crystal-forming oligomers for use in radiation-carable fiber optic coatings | DSM IP �Ʋ�����˾ | 2004-03-24 | — | — | CN | disclosed |
| US-20010051672-A1 | Dental material based on cationically polymerizable monomers | DEGUSSA DENTAL GMBH & CO. KG (DE) | 2001-12-13 | — | — | US | disclosed |
| EP-1146066-A1 | Ormocers, process for their production and use | Degussa Dental GmbH & Co. KG (DE) | 2001-10-17 | — | — | EP | disclosed |
| EP-1138309-A2 | Dental composition based on cationically polymerisable monomers | Degussa Dental GmbH & Co. KG (DE) | 2001-10-04 | — | — | EP | disclosed |
| EP-0914360-A1 | METHOD FOR PRODUCING A SHAPED PIECE SUITABLE FOR OPTICAL PURPOSES | Institut Für Neue Materialien gem. GmbH (DE) | 1999-05-12 | — | — | EP | disclosed |
| WO-1998004604-A1 | METHOD FOR PRODUCING A SHAPED PIECE SUITABLE FOR OPTICAL PURPOSES | INSTITUT FÜR NEUE MATERIALIEN GEM. GMBH (DE) | 1998-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051672-A1 | Dental material based on cationically polymerizable monomers | SMCHD1, SMC2, SMC1A | KDM4E 156/4885FAAH 3444/4885CTSK 4641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.